Publication | Closed Access

Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population

Hematological MalignancyChronic Myeloid LeukemiaOncologyMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyMyeloid NeoplasiaPathologyMedicineImatinib MesylateCancer ResearchChinese Population